JY
FLNA

Jeff Yass’s Filana Therapeutics FLNA Stock Holding History

Jeff Yass’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
102,100
-75,400
-42% -$107K ﹤0.01% 12363
2026
Q1 		$300K Sell
177,500
-204,800
-54% -$422K ﹤0.01% 10857
2025
Q4 		$757K Buy
382,300
+242,000
+172% +$775K ﹤0.01% 7844
2025
Q3 		$408K Sell
140,300
-107,200
-43% -$247K ﹤0.01% 9428
2025
Q2 		$448K Sell
247,500
-61,000
-20% -$109K ﹤0.01% 9431
2025
Q1 		$463K Sell
308,500
-2,189,800
-88% -$5.53M ﹤0.01% 9064
2024
Q4 		$5.9M Buy
2,498,300
+1,079,200
+76% +$19M ﹤0.01% 3357
2024
Q3 		$41.8M Buy
1,419,100
+987,900
+229% +$22.8M 0.01% 1213
2024
Q2 		$5.33M Buy
431,200
+288,700
+203% +$6.09M ﹤0.01% 3342
2024
Q1 		$2.89M Sell
142,500
-239,700
-63% -$5.52M ﹤0.01% 4595
2023
Q4 		$8.6M Sell
382,200
-83,900
-18% -$1.77M ﹤0.01% 2835
2023
Q3 		$7.76M Buy
466,100
+167,400
+56% +$3.32M ﹤0.01% 2884
2023
Q2 		$7.32M Sell
298,700
-11,000
-4% -$265K ﹤0.01% 2936
2023
Q1 		$7.47M Sell
309,700
-351,500
-53% -$9.74M ﹤0.01% 2872
2022
Q4 		$19.5M Sell
661,200
-246,900
-27% -$8.87M ﹤0.01% 1545
2022
Q3 		$38M Buy
908,100
+213,500
+31% +$5.77M 0.01% 973
2022
Q2 		$19.5M Sell
694,600
-233,200
-25% -$5.89M ﹤0.01% 1471
2022
Q1 		$34.5M Sell
927,800
-224,300
-19% -$9.5M 0.01% 1242
2021
Q4 		$50.3M Sell
1,152,100
-374,200
-25% -$19.6M 0.01% 1087
2021
Q3 		$94.8M Buy
1,526,300
+1,024,200
+204% +$85.5M 0.01% 806
2021
Q2 		$42.9M Buy
502,100
+53,100
+12% +$2.84M 0.01% 1311
2021
Q1 		$20.2M Buy
449,000
+192,400
+75% +$7.57M ﹤0.01% 1858
2020
Q4 		$1.75M Buy
256,600
+135,600
+112% +$1.21M ﹤0.01% 5381
2020
Q3 		$1.39M Sell
121,000
-16,300
-12% -$73.5K ﹤0.01% 5331
2020
Q2 		$423K Buy
137,300
+89,400
+187% +$405K ﹤0.01% 7721
2020
Q1 		$197K Buy
+47,900
New +$317K ﹤0.01% 8714
2014
Q1 		– Sell
-3,000
Closed -$102K – 9347
2013
Q4 		$102K Buy
3,000
+43
+1% +$1.14K ﹤0.01% 8629
2013
Q3 		$56K Buy
+2,957
New +$51.7K ﹤0.01% 8209

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jeff Yass's FLNA Position: Q2 2026 in Review

Jeff Yass reduced its Filana Therapeutics (FLNA) stake by 35% in Q2 2026, selling an estimated $221K and leaving 292,017 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #10732.

Jeff Yass first reported a position in FLNA in Q2 2013 and has held it in 50 quarters since. The position peaked at $30M in Q2 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Jeff Yass held 292,017 shares of Filana Therapeutics worth $348K as of Q2 2026.
  • Jeff Yass sold 155,261 Filana Therapeutics shares in Q2 2026, an estimated $221K.
  • Filana Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10732 holding.
  • Jeff Yass first reported a position in Filana Therapeutics in Q2 2013 and has held it in 50 quarters since.
  • Jeff Yass's Filana Therapeutics position peaked at $30M in Q2 2021.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.